Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia

This study has been terminated.

(Overall profile of the compound does not offer significant clinical advantage to patients over currently available lipid lowering agents)

Sponsor:

Information provided by (Responsible Party):

Takeda Global Research & Development Center, Inc. ( Takeda Global Research & Development Centre (Europe) Ltd. )

ClinicalTrials.gov Identifier:

NCT00532558

First received: September 18, 2007

Last updated: May 23, 2012

Last verified: May 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	May 2008
Primary Completion Date:	May 2008 (Final data collection date for primary outcome measure)